挪威2020至2023年母亲和婴儿对百日咳博德特菌的免疫状况
该前瞻性观察研究纳入2020至2023年366对母婴,检测孕期、脐带血及婴儿首剂前后和第三剂后的百日咳抗体。48%(174/366)孕妇抗百日咳毒素(PT)IgG低于5 IU/mL,72%(154/215)婴儿首剂前抗PT IgG低于5 IU/mL,所有婴儿对疫苗接种应答良好。结果支持在挪威引入孕期百日咳疫苗接种。
要点
- 48%(174/366)孕妇抗PT IgG低于5 IU/mL。
- 72%(154/215)婴儿首剂前抗PT IgG低于5 IU/mL。
- 所有婴儿对疫苗接种应答良好,未发现高母体抗体(>40 IU/mL)的钝化证据。
核心结论
- 高比例孕妇和3月龄以下婴儿抗PT抗体水平低,提示对百日咳高度易感,结果支持在挪威引入孕期百日咳疫苗接种。
研究设计与样本
- 前瞻性观察研究,2020至2023年纳入366对母婴,采集孕晚期母亲血、分娩时脐带血及婴儿首剂前和第三剂后血样,并从健康登记处获取疫苗接种和妊娠相关信息。
主要发现
- 48%(174/366)孕妇抗PT IgG低于5 IU/mL。
- 婴儿从出生至首剂接种前母体抗体下降,72%(154/215)婴儿抗PT IgG低于5 IU/mL。
- 所有婴儿对疫苗接种应答良好,未发现高母体抗PT抗体(>40 IU/mL)导致钝化的证据。
- 妊娠前2年内接种含aP加强疫苗的母亲所生婴儿抗PT IgG水平低,58%(15/26)低于5 IU/mL。
临床怎么用
- 作者认为结果支持在挪威引入孕期百日咳疫苗接种。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDPertussis remains a serious threat to young infants. In Norway, infants receive an acellular pertussis vaccine (aP) according to a 2 + 1 schedule at 3, 5 and 12 months of age, delivered as a hexavalent vaccine.AIMWe aimed to study susceptibility to pertussis in mothers and infants to guide decisions regarding vaccination in pregnancy.METHODSIn this prospective observational study, we included 366 mother/infant pairs during 2020-2023, collecting blood samples from mothers in late pregnancy, cord blood at delivery and from infants before their first and after their third vaccine dose. We retrieved health registry data on vaccination and pregnancy-related information. IgG antibody levels against pertussis-antigens, diphtheria and tetanus were measured using a multiplex immunoassay.RESULTSOf the pregnant women, 48% (174/366) had low levels of antibodies against pertussis toxin (PT) defined as below 5 IU/mL. Maternal antibodies declined in infants from birth until first vaccination, leaving 72% (154/215) of infants with anti-PT IgG levels below 5 IU/mL. All infants responded well to vaccination and we found no evidence of blunting from high levels (> 40 IU/mL) of maternal antibodies against PT. Infants of mothers who received an aP-containing booster vaccine within 2 years before pregnancy displayed low anti-PT IgG levels, with 58% (15/26) having levels below 5 IU/mL.CONCLUSIONA high proportion of pregnant women and their infants under 3 months of age had low anti-PT antibody levels, indicating high susceptibility to pertussis. The results support the introduction of vaccination against pertussis during pregnancy in Norway.
引用
- Greve-Isdahl M, Møller TKR, Bekkevold T, et al. Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023. Euro Surveill. 2025. PMID: 41414933. doi:10.2807/1560-7917.ES.2025.30.50.2500450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。